Clinical Trials

FDA Advisory Panel Backs Grail’s Galleri Blood Test but Flags Key Evidence Gaps

The panel’s votes clear a major regulatory hurdle and send the application to the FDA for a final decision while regulators seek strict labeling and more outcome data.